Research presented at the 2017 European Cancer Congress describes the potential of a noninvasive diagnostic test for esophageal and gastric cancers that measures chemicals in the breath.
Researchers reveal that miR-17 appears to be important in driving esophageal tumor resistance to radiotherapy.
Drug-drug interaction between capecitabine and common heartburn medications has a negative effect on progression-free survival and overall survival in patients with GI cancer.
A retrospective evaluation investigated the association between risk of esophageal cancer, metabolic syndrome, Barrett esophagus, and GERD in older persons.
[Journal of Gastrointestinal Oncology] This research examines factors associated with survival in patients with brain metastasis from esophageal cancer.
Applying evolutionary theory improves the accuracy of predicting in which patients Barrett's esophagus will progress to esophageal adenocarcinoma.
Using a computer algorithm to scan images of the esophagus for signs of early esophageal cancer is nearly as accurate as top specialists.
Drinking scalding coffee, tea, or yerba mate might increase the risk of developing esophageal cancer according to the World Health Organization. Beverages hotter than 149°F (65°C) might increase the risk of developing esophageal cancer.
Bacteria that cause gum disease, Porphyromonas gingivalis, frequently infect the esophageal tissues of patients with esophageal squamous cell carcinoma (ESCC), were associated with ESCC progression, and serve as a potential biomarker for ESCC.
Gains in surgical proficiency in esophagectomy for cancer are associated with measurable improvements in short-term and long-term mortality results.
Reliance on PET to Detect Lung or Esophageal Cancer Recurrence May Lead to Overuse of the Imaging ModalityMarch 09, 2016
In posttreatment follow-up of lung and esophageal cancer, PET scans might be overused to detect cancer recurrence. Furthermore, PET scan use to detect recurrence does not increase survival.
Chemosensory and food-related changes significantly impacted food preferences and had practical and social consequences.
No significant difference in survival was observed with VTE, but odds of esophageal cancer ecurrence are increased.
Endoscopic submucosal dissection is found to be a safe and effective treatment for patients with superficial pharyngeal cancer, according to a recent study.
Mortality Rates in Patients With Esophageal Cancer Are Lower With The Use of Intensity-modulated RadiotherapyJanuary 07, 2016
Intensity-modulated radiotherapy (IMRT) is significantly associated with lower all-cause, cardiac, and other-cause mortality rates in patients with esophageal cancer.
Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal CancerNovember 27, 2015
The purpose of this research was to examine both efficiency and safety of concurrent chemoradiotherapy (CCRT) using paclitaxel combined with cisplatin in elderly esophageal cancer patients.
A phase Ia clinical trial demonstrated that Tregs, immune cells that can inhibit anticancer immune responses, were efficiently eliminated from the blood of patients with lung or esophageal cancer when treated with the investigational therapeutic antibody KW-0761.
A nurse-led walk-and-eat intervention is feasible and effective to preserve functional walking capacity and nutritional status in patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy.
New procedure allows doctors to collect cells from all along the esophagus, whereas standard biopsies take individual point samples.
New research indicates that treating patients with esophageal cancer with proton therapy produces fewer toxic side effects than utilizing older radiation therapies.
The rate of esophageal cancer rates in men have climbed radically since the 1980s, according to new statistics from Cancer Research UK.
Patients with esophageal cancer treated with proton therapy experienced significantly fewer adverse events.
A new study focuses on survival outcomes of patients with locally advanced esophageal cancer (LAEC) beyond the 5-year mark.
Improved survival and treatment response was seen in HPV-16 positive patients.
Overweight children may have an increased risk for esophageal cancer when grow up compared with slimmer children.
A new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus.
According to a new study published in the Journal of Clinical Oncology, researchers have found that in patients with esophageal cancer and no history of psychiatric morbidity, psychiatric morbidity increases following surgery.
Patients with a specific type of esophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results.
The esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
Risks of claims alleging failure to screen for esophageal cancer arising from acts of commission, omission are similarly low.
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- CRISPR Illustrates Progression of Normal Blood Cells to Leukemia, Precursor Diseases
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Internet-based Cognitive Behavioral Therapy Beneficial for Improving Sexual Functioning
- Tattoo Transforms Mastectomy Scars Into Personal Art for Breast Cancer Survivors
- Specialized Cancer Centers May Improve Outcomes in Children with Leukemia
- ASTRO Issues Updated Guidelines on Palliative Radiation Therapy
- Patients With a Recurrence Score of 11 to 25 May Not Benefit from Chemo
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|